Share on StockTwits

Ducommun (NYSE:DCO) Director Joseph C. Berenato sold 1,000 shares of the company’s stock on the open market in a transaction dated Friday, June 27th. The stock was sold at an average price of $25.37, for a total transaction of $25,370.00. Following the sale, the director now directly owns 15,793 shares in the company, valued at approximately $400,668. The sale was disclosed in a filing with the SEC, which can be accessed through this link.

Ducommun (NYSE:DCO) opened at 26.19 on Monday. Ducommun has a 52-week low of $20.40 and a 52-week high of $31.35. The stock’s 50-day moving average is $25.25 and its 200-day moving average is $26.15. The company has a market cap of $284.3 million and a price-to-earnings ratio of 28.07.

Ducommun (NYSE:DCO) last issued its quarterly earnings data on Monday, April 28th. The company reported $0.42 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.32 by $0.10. The company had revenue of $179.80 million for the quarter, compared to the consensus estimate of $179.61 million. During the same quarter in the prior year, the company posted $0.35 earnings per share. The company’s quarterly revenue was up 2.2% on a year-over-year basis. On average, analysts predict that Ducommun will post $1.65 earnings per share for the current fiscal year.

A number of analysts have recently weighed in on DCO shares. Analysts at Topeka Capital Markets initiated coverage on shares of Ducommun in a research note on Tuesday, June 24th. They set a “hold” rating and a $27.00 price target on the stock. Analysts at DA Davidson raised their price target on shares of Ducommun from $25.00 to $28.00 in a research note on Tuesday, April 29th. They now have a “neutral” rating on the stock. Four research analysts have rated the stock with a hold rating and three have issued a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and an average price target of $31.36.

Ducommun Incorporated (NYSE:DCO) provides engineering and manufacturing services primarily in the aerospace, defense, industrial, energy, and medical industries.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.